Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/23/26 17:34 | 1/21/26 | RNA | Health | Drug | Pharmaceutical Preparations | Hughes Steven George | CA | O | Chief Me | 2 | S | -526 | 72.38 | 0 | -7 | 36 | D | |||||||||||||||
1/23/26 17:34 | 1/21/26 | RNA | Health | Drug | Pharmaceutical Preparations | Boyce Sarah | CA | DO | P,CEO | 2 | S | -1,662 | 72.37 | 0 | -23 | 283 | D | |||||||||||||||
1/23/26 17:33 | 1/21/26 | RNA | Health | Drug | Pharmaceutical Preparations | Flanagan W. Michael | CA | O | Chief Sc | 2 | S | -645 | 72.39 | 0 | -9 | 92 | D | |||||||||||||||
1/23/26 17:33 | 1/21/26 | RNA | Health | Drug | Pharmaceutical Preparations | Maclean Michael F | CA | O | CFO | 2 | S | -472 | 72.38 | 0 | -7 | 64 | D | |||||||||||||||
1/23/26 17:33 | 1/21/26 | RNA | Health | Drug | Pharmaceutical Preparations | Levin Arthur A | CA | D | 1 | S | -127 | 72.45 | 0 | -2 | 170 | D | ||||||||||||||||
1/23/26 17:33 | 1/21/26 | RNA | Health | Drug | Pharmaceutical Preparations | McCarthy Teresa | CA | O | CHRO | 2 | S | -354 | 72.36 | 0 | -5 | 117 | D | |||||||||||||||
1/9/26 17:13 | 1/7/26 | RNA | Health | Drug | Pharmaceutical Preparations | Calderaro Charles III | CA | O | Chief Te | 1 | S | -269 | 72.23 | 0 | -4 | 50 | D | |||||||||||||||
1/9/26 17:12 | 1/7/26 | RNA | Health | Drug | Pharmaceutical Preparations | Moriarty John B | CA | O | GC | 1 | S | -171 | 72.23 | 0 | -2 | 75 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |